BDBM525574 (S)-5-(1-(6- (hexahydropyrazino[2,1- c][1,4]oxazin-8(1H)-yl)-2- methylpyrimidin-4-yl)-1H- indazol-6- yl)spiro[2.3]hexane-5- carbonitrile::US11174248, Example 47

SMILES Cc1nc(cc(n1)-n1ncc2ccc(cc12)C1(CC2(CC2)C1)C#N)N1CCN2CCOC[C@@H]2C1

InChI Key InChIKey=OLBOJFCWNRYQEP-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 525574   

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM525574((S)-5-(1-(6- (hexahydropyrazino[2,1- c][1,4]oxazin...)
Affinity DataIC50: 3.20nMAssay Description: Assays were performed in the presence of 134 μM ATP (Km ATP). Upon completion, the assay was stopped and phosphorylated substrate detected with...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/3/2022
Entry Details
Go to US Patent